| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,796,828 |
|
|
|
Indirect Value
|
$4,756,396 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,553,224 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-01-18 |
4 |
AS |
$7.48 |
$19,121 |
D/D |
(2,500) |
1,264,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-01-23 |
4 |
AS |
$6.83 |
$17,701 |
D/D |
(2,500) |
1,261,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-01-28 |
4 |
AS |
$6.99 |
$17,842 |
D/D |
(2,500) |
1,259,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-02-06 |
4 |
AS |
$6.75 |
$17,178 |
D/D |
(2,500) |
1,256,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-02-13 |
4 |
AS |
$6.96 |
$17,630 |
D/D |
(2,500) |
1,254,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-02-22 |
4 |
AS |
$5.77 |
$14,609 |
D/D |
(2,500) |
1,251,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-02-27 |
4 |
AS |
$6.38 |
$16,349 |
D/D |
(2,500) |
1,249,415 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2008-08-26 |
4 |
B |
$2.70 |
$27,000 |
D/D |
10,000 |
33,188 |
2.39 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-10-30 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
1,174,415 |
2.81 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2010-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
63,165 |
63,165 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-14 |
4 |
D |
$104.00 |
$914,264 |
D/D |
(8,791) |
54,374 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,341 |
75,715 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-15 |
4 |
D |
$104.00 |
$926,744 |
D/D |
(8,911) |
66,804 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-20 |
4 |
AS |
$105.94 |
$1,315,033 |
D/D |
(12,347) |
54,457 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
73,290 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-02-10 |
4 |
D |
$118.14 |
$827,807 |
D/D |
(7,007) |
66,283 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-02 |
4 |
AS |
$143.50 |
$169,761 |
D/D |
(1,183) |
63,917 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
85,256 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-16 |
4 |
D |
$144.61 |
$2,556,560 |
D/D |
(17,679) |
67,577 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-17 |
4 |
AS |
$146.04 |
$361,011 |
D/D |
(2,472) |
65,105 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-08-01 |
4 |
AS |
$146.30 |
$534,727 |
D/D |
(3,655) |
61,450 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-09-04 |
4 |
AS |
$145.90 |
$533,119 |
D/D |
(3,654) |
57,796 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-10-01 |
4 |
AS |
$149.16 |
$545,031 |
D/D |
(3,654) |
54,142 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-01 |
4 |
AS |
$138.64 |
$344,640 |
D/D |
(2,472) |
51,670 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,756 |
5,378 |
0 |
- |
|
376 Records found
|
|
Page 9 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
